Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The anticoagulants market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of almost 9%, as per The Business Research Company’s market report!

Read More On The Anticoagulants Market Report 2022 – https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

The Anticoagulants Market Size In 2022 And Forecast

The global anticoagulants market is expected to grow from $32.09 billion in 2020 to $36.50 billion in 2021 at a compound annual growth rate (CAGR) of 13.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The anticoagulants market is expected to reach $51.32 billion in 2025 at a CAGR of 8.9%.

The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots.

Request for A Free Sample Of The Global Anticoagulants Market Report:

 https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

Increase In Cardiovascular Diseases Is Driving The Growth Of The Anticoagulants Market

According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.

Competitive Landscape And The Regional Analysis Of The Anticoagulants Market

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka and Leo Pharma.

The Anticoagulants Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the anticoagulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the anticoagulants market.

Ongoing Clinical Trials Of Anticoagulant Treatments For COVID-19 – A Key Trend In The Anticoagulants Market

Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19-related blood clotting in adults.

Anticoagulants Market Segmentation By The Business Research Company

1) By Drug Class: Factor Xa Inhibitor, Heparin and LMWH, Vitamin K Antagonist, Others

2) By Route of Administration: Oral Anticoagulant, Injectable Anticoagulant

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By Application: Venous Thromboembolism, Atrial Fibrillation or Flutter, Coronary Artery Disease, Others

5) By End-User: Hospitals, Homecare, Specialty Centers, Others

Here Are Some Reports Related To The Anticoagulants Market –

Anti-Hypertensive Drugs Global Market Report 2022

Antivirals Global Market Report 2022

Blood Transfusion Diagnostics Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: